Adamas Pharmaceuticals Inc (ADMS) Inventory Turnover Ratio, from third quarter 2021 to third quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)
 

Adamas Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Adamas Pharmaceuticals Inc's Inventory turnover ratio has remained unchanged compare to previous quarter at 0.27 in the third quarter 2021Average processing period, for Adamas Pharmaceuticals Inc's inventories remained unchanged at 1352 days, in the Sep 30 2021 quarter.

Within Healthcare sector 390 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1961 in the second quarter 2021, to 1962.

ADMS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Adamas Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADMS Inventory Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Inventory Growth 26.64 % 33.11 % 40.05 % 38.48 % 33.87 %
Y / Y Cost of Sales Growth 18.03 % 38.32 % -32.69 % 35.07 % -47.47 %
Inventory Turnover Ratio (TTM) 0.27 0.27 0.27 0.32 0.32
ADMS's Total Ranking # 1962 # 1961 # 1961 # 1961 # 1960
Average inventory processing period 1370 1347 1357 1136 1132
Seq. Inventory Growth 11.45 % 3.34 % 3.32 % 6.42 % 17.14 %
Seq. Cost of Sales Growth 9.3 % 36.88 % -35.51 % 22.34 % 28.08 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 133
Healthcare Sector # 391
Overall Market # 1962

Inventory Turnover Ratio Statistics
High Average Low
0.49 0.29 0.06
(Mar 31 2020)   (Jun 30 2018)



ADMS Company Profile >> Back to ADMS Efficiency Comparisons >> Compare ADMS Inventory Turnover Ratio to its Competitors

Financial Statements
Adamas Pharmaceuticals Inc's Inventories $ 9 Millions Visit ADMS's Balance sheet
Adamas Pharmaceuticals Inc's Cost of Revenues TTM $ 2 Millions Visit ADMS's Income Statement
What are ADMS's Sales? Visit ADMS's Sales by Segment

Other Inventory Turnover Ratios
Adamas Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADMS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADMS's Competitors
Inventory Turnover Ratio for ADMS's Suppliers
Inventory Turnover Ratio for ADMS's Customers

You may also want to know
ADMS's Sales Growth Rates ADMS's Pe Price to earnings ratio ADMS's Receivables Turnover Ratio ADMS's Stock Quote
ADMS's Net Income Growth Rates ADMS's Ps Price to Sales ratio ADMS's Sales per Employee ADMS's Asset Turnover Ratio
ADMS's Net Margin ADMS's Pb Price to Book ratio ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2021 Inventories at quarter ending Sep 30 2021
Regeneron Pharmaceuticals Inc   0.63 $ 1,273.700  Millions$ 2,030  Millions
Ionis Pharmaceuticals Inc   0.52 $ 11.916  Millions$ 23  Millions
Agape Atp Corporation  0.51 $ 0.267  Millions$ 1  Millions
Bionik Laboratories Corp   0.48 $ 0.348  Millions$ 1  Millions
Neurocrine Biosciences Inc   0.47 $ 13.100  Millions$ 28  Millions
American Cryostem Corporation  0.44 $ 0.010  Millions$ 0  Millions
Invo Fertility Inc   0.40 $ 0.108  Millions$ 0  Millions
Orthopediatrics Corp  0.39 $ 21.720  Millions$ 55  Millions
Deciphera Pharmaceuticals Inc   0.36 $ 2.541  Millions$ 7  Millions
Emmaus Life Sciences Inc   0.32 $ 2.151  Millions$ 7  Millions
Evofem Biosciences Inc   0.27 $ 2.451  Millions$ 9  Millions
Adamas Pharmaceuticals Inc  0.27 $ 2.085  Millions$ 8  Millions
Bespoke Extracts Inc  0.26 $ 0.014  Millions$ 0  Millions
Siga Technologies Inc  0.25 $ 5.662  Millions$ 22  Millions
One World Products Inc   0.25 $ 0.095  Millions$ 0  Millions
Motus Gi Holdings Inc   0.23 $ 0.158  Millions$ 1  Millions
Streamex Corp   0.20 $ 0.199  Millions$ 1  Millions
Orchard Therapeutics Plc  0.18 $ 0.227  Millions$ 1  Millions
Guided Therapeutics Inc   0.17 $ 0.101  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  0.16 $ 0.917  Millions$ 6  Millions
Ptc Therapeutics inc   0.13 $ 2.200  Millions$ 17  Millions
Natus Medical Inc  0.10 $ 6.929  Millions$ 71  Millions
Cytodyn inc   0.09 $ 6.598  Millions$ 74  Millions
Global Blood Therapeutics Inc.  0.07 $ 3.123  Millions$ 45  Millions
Innovation1 Biotech Inc   0.05 $ 0.001  Millions$ 0  Millions
Palatin Technologies Inc   0.05 $ 0.177  Millions$ 4  Millions

Date modified: 2026-08-29T17:26:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.